Ipilimumab/pembrolizumabHypophysitis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1909卷 / 1期

关键词：

D O I：

10.1007/s40278-022-16593-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：306 / 306

相关论文

共 50 条

[41] Ipilimumab/nivolumabHyperthyroidism: case report
Reactions Weekly, 2022, 1916 (1) : 241 - 241
[42] Ipilimumab/nivolumabMyocarditis : case report
Reactions Weekly, 2023, 1951 (1) : 187 - 187
[43] Ipilimumab/sintilimabAsthma: case report
Reactions Weekly, 2022, 1890 (1) : 143 - 143
[44] Ipilimumab/nivolumabMyocarditis: case report
Reactions Weekly, 2022, 1887 (1) : 397 - 397
[45] Ipilimumab/nivolumabMyocarditis: case report
Reactions Weekly, 2019, 1751 (1) : 217 - 217
[46] Ipilimumab/nivolumabMyocarditis: case report
Reactions Weekly, 2022, 1920 (1) : 268 - 268
[47] Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly, 2021, 1847 (1) : 259 - 259
[48] Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly, 2023, 1954 (1) : 261 - 261
[49] Ipilimumab/NivolumabPancreatitis: case report
Reactions Weekly, 2024, 2026 (1) : 162 - 162
[50] Ipilimumab/nivolumabPapilloedema: case report
Reactions Weekly, 2019, 1768 (1) : 198 - 198

← 1 2 3 4 5 →